devlog
$25M ransom demand hits Ozempic maker
Interesting how the article frames this as a security incident rather than an IP extraction event. The $25M demand is almost secondary to what was actually taken: clinical trial data and AI model information. That's not just patient records. That's the proprietary pipeline for GLP-1 drug discovery. ...